"Atrium Health Urology Kenilworth, located in Charlotte, NC, encompasses expertise in treatment, state-of-the-art technology, and dedication to education and innovative research. The staff works together to provide patients with expert, personalized care, and a full range of treatment and surgical options for most major urologic conditions."

During the past decade, McKay Urology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 10 clinical trials were completed, i.e. on average, 142.9% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "McKay Urology" #1 sponsor was "Allergan" with 4 trials, followed by "Cook MyoSite" with 3 trials sponsored, "Dendreon" with 3 trials sponsored, "Coloplast A/S" with 2 trials sponsored and "Ethicon Endo-Surgery" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "McKay Urology" #1 collaborator was "Data & Inference, Inc." with 2 trials as a collaborator, "Novella Clinical" with 2 trials as a collaborator and "Regulatory and Clinical Research Institute (RCRI)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "McKay Urology" are "Stress Urinary Incontinence" (5 trials), "Urinary Incontinence" (3 trials), "Cystitis, Interstitial" (2 trials), "Overactive Bladder" (2 trials) and "Prostate Cancer" (2 trials). Many other conditions were trialed in "McKay Urology" in a lesser frequency.

Most popular intervention types in "McKay Urology" are "Biological" (8 trials), "Device" (6 trials), "Drug" (4 trials), "Other" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "LiRIS Placebo" (2 trials), "LiRIS®" (2 trials), "OnabotulinumtoxinA" (2 trials) and "Sipuleucel-T" (2 trials). Other intervention names were less common.

The vast majority of trials in "McKay Urology" are 8 trials for "Male" genders, 6 trials for "Female" genders and 5 trials for "All" genders.

Currently, there are NaN active trials in "McKay Urology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in McKay Urology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in McKay Urology, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".